By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Preview - This content has been restricted to logged in users only.
Supersaturation ability of Soluplus® and Kollidon® VA 64 with low soluble compound Meloxicam as model drug by real time concentration monitoring and dissolution
This study was aimed at comparing the supersaturation ability of Soluplus® and Kollidon® VA 64 with low soluble compound Meloxicam as a model drug by using real time concentration monitoring and dissolution – permeability setup.